Your browser doesn't support javascript.
loading
A bispecific Clec9A-PD-L1 targeted type I interferon profoundly reshapes the tumor microenvironment towards an antitumor state.
Van Lint, Sandra; Van Parys, Alexander; Van Den Eeckhout, Bram; Vandamme, Niels; Plaisance, Stephane; Verhee, Annick; Catteeuw, Dominiek; Rogge, Elke; De Geest, Jennifer; Vanderroost, Nele; Roels, Jana; Saeys, Yvan; Uzé, Gilles; Kley, Niko; Cauwels, Anje; Tavernier, Jan.
Afiliação
  • Van Lint S; Center for Medical Biotechnology, VIB & Department of Biomolecular Medicine, Ghent University, Ghent, Belgium.
  • Van Parys A; Cancer Research Institute Ghent (CRIG), Ghent, Belgium.
  • Van Den Eeckhout B; Center for Medical Biotechnology, VIB & Department of Biomolecular Medicine, Ghent University, Ghent, Belgium.
  • Vandamme N; Cancer Research Institute Ghent (CRIG), Ghent, Belgium.
  • Plaisance S; Present Affiliation: Orionis Biosciences, Ghent, Belgium.
  • Verhee A; Center for Medical Biotechnology, VIB & Department of Biomolecular Medicine, Ghent University, Ghent, Belgium.
  • Catteeuw D; Cancer Research Institute Ghent (CRIG), Ghent, Belgium.
  • Rogge E; Cancer Research Institute Ghent (CRIG), Ghent, Belgium.
  • De Geest J; VIB Single Cell Core, VIB, Ghent-Leuven, Belgium.
  • Vanderroost N; Department of Biomedical Molecular Biology, Ghent University, Ghent, Belgium.
  • Roels J; VIB Nucleomics Core, Leuven, Belgium.
  • Saeys Y; Center for Medical Biotechnology, VIB & Department of Biomolecular Medicine, Ghent University, Ghent, Belgium.
  • Uzé G; Center for Medical Biotechnology, VIB & Department of Biomolecular Medicine, Ghent University, Ghent, Belgium.
  • Kley N; Center for Medical Biotechnology, VIB & Department of Biomolecular Medicine, Ghent University, Ghent, Belgium.
  • Cauwels A; Present Affiliation: Orionis Biosciences, Ghent, Belgium.
  • Tavernier J; Center for Medical Biotechnology, VIB & Department of Biomolecular Medicine, Ghent University, Ghent, Belgium.
Mol Cancer ; 22(1): 191, 2023 11 29.
Article em En | MEDLINE | ID: mdl-38031106

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Interferon Tipo I / Neoplasias Limite: Humans Idioma: En Revista: Mol Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Bélgica

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Interferon Tipo I / Neoplasias Limite: Humans Idioma: En Revista: Mol Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Bélgica